Abbott stock falls following retrial order in infant formula case
The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, ...
He Fought Claims of Harm From Infant Formula. Now He Regulates It.
Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula.
Padeiatricans’ summit sponsored by infant formula maker in violation of law
Abbott Nutrition is sponsoring a national paediatrics summit in Dehradun, despite laws prohibiting baby food manufacturers ...
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. If we consider the ...
Abbott, Apple, Citi, Nexstar, Musk, OpenAI: Votes and Verdicts
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...
Nasdaq21d
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Abbott (ABT) closed at $133.17 ... Coming into today, shares of the maker of infant formula, medical devices and drugs had gained 12.18% in the past month.